AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 207 filers reported holding AMICUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,874,000 | +212.9% | 155,044 | +304.4% | 0.24% | +158.1% |
| Q2 2018 | $599,000 | -69.3% | 38,344 | -70.5% | 0.09% | -20.5% |
| Q1 2018 | $1,952,000 | +550.7% | 129,820 | +115.3% | 0.12% | +588.2% |
| Q4 2016 | $300,000 | -56.3% | 60,309 | -52.1% | 0.02% | -52.8% |
| Q2 2016 | $687,000 | +37.1% | 125,912 | +112.2% | 0.04% | +44.0% |
| Q1 2016 | $501,000 | +101.2% | 59,324 | +131.2% | 0.02% | +78.6% |
| Q4 2015 | $249,000 | -87.9% | 25,661 | -89.6% | 0.01% | -78.5% |
| Q4 2014 | $2,053,000 | +514.7% | 246,697 | +146.7% | 0.06% | +364.3% |
| Q2 2014 | $334,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |